Stock Price Quote

SHRISHMA FINE CHEMICALS & PHARMA. (KARNATAKA.) LTD.

NSE : NABSE : 507000ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.420 (0 %)
PREV CLOSE ( ) 0.42
OPEN PRICE ( ) 0.42
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.42 0.42
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1981
Management Info
R N Goel - Chairman R N Goel - Managing Director
Registered Office

Address Plot No 30, Industrial Area,,
Doddaballapur,
Karnataka-561203

Phone 08119- 22346 23806 23813

Email --

Website NA

Registrars Details
Shrishma Fine Chemicals & Pharma. (Karnataka.) Ltd.
Plot No 30, Industrial Area,,Doddaballapur
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR Sep 04 ANNUAL 01
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2585.70 (1.70%)
M.Cap ( in Cr)1570.82
Mercury Laboratories (BSE)
peergroup  924.00 (3.81%)
M.Cap ( in Cr)106.81
Sanjivani Paranteral (BSE)
peergroup  182.95 (8.51%)
M.Cap ( in Cr)197.00
TTK Healthcare (BSE)
peergroup  1541.25 (0.80%)
M.Cap ( in Cr)2160.60
Chandra Bhagat Pharm (BSE)
peergroup  113.85 (11.60%)
M.Cap ( in Cr)76.97

Shareholding Pattern

No Data Found

About Shrishma Fine Chemicals & Pharma. (Karnataka.) Ltd.

Shrishma Fine Chemicals & Pharma. (Karnataka.) Ltd. was incorporated in the year 1981. Its today's share price is 0.42. Its current market capitalisation stands at Rs 0.76 Cr. In the latest quarter, company has reported Gross Sales of Rs. 21.03 Cr and Total Income of Rs.19.9 Cr. The company's management includes P P Madappa, S R Goel, R N Goel, R N Goel, Walter Saldanha, Pravin Vepari, N Ramakrishnan.

It is listed on the BSE with a BSE Code of 507000 , NSE with an NSE Symbol of and ISIN of . It's Registered office is at Plot No 30, Industrial Area,Doddaballapur-561203, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.